Michael Dicello, MD
Allergy & Immunology · Bozeman, MTNPI 1720083173
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,000 of the $10,519 with a category attached, or 95.1%. GSK accounts for 95.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $10,094 and has fallen 97.8% since, to $218 in 2025.
Across 19 payments — averaging $553.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$10K
- Blueprint Medicines Corporation$146
- Regeneron Healthcare Solutions, Inc.$138
- Takeda Pharmaceuticals U.S.A., Inc.$76
- Teva Pharmaceuticals USA, Inc.$25
- Genentech USA, Inc.$22
- plus $53 from 3 others
What the payments were for
- Speaking & faculty fees$10,00095%
- Food & beverage$3804%
- Education$1391%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 4 | $10,058 |
| Blueprint Medicines Corporation | 2 | $146 |
| Regeneron Healthcare Solutions, Inc. | 3 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $76 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $22 |
| Pfizer | 1 | $21 |
| Sanofi | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AYVAKIT$120
How this compares
Too few allergy & immunology providers in Montanato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 30 | $113,194 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 26 | $59,072 |
| XolairOmalizumab | 23 | $48,976 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 60 | $40,206 |
| Advair HfaFluticasone Propion/Salmeterol | 42 | $22,636 |
| Breo ElliptaFluticasone/Vilanterol | 49 | $21,506 |
| Spiriva RespimatTiotropium Bromide | 29 | $20,954 |
| Incruse ElliptaUmeclidinium Bromide | 28 | $12,136 |
| DuleraMometasone/Formoterol | 21 | $11,195 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 23 | $9,489 |
| Fluticasone Propionate HfaFluticasone Propionate | 43 | $9,099 |
| Arnuity ElliptaFluticasone Furoate | 43 | $9,013 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 30 | $5,197 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 18 | $3,513 |
| Epinephrine | 12 | $2,808 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta | $10,058 | $82,860180 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy & immunology providers in Montanaon file to place this against a meaningful peer group, so we don't.
Other allergy & immunology in Bozeman
- Michael ZacharisenBozeman$5K
- Alan WandererBozeman$194
- Carl ThornbladeMissoula$26K
- Thomas ScarboroughBillings$3K
- Elaine BarbieriGreat Falls$2K
- Juan AdamsBillings$2K
- Summer MonforteHelena$441
- Carol CadyMissoula$96
- Kathleen DavisBillings$18
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.